Completed Plants, Animals & Ecology Infection & Immunity

Preparing to Scale Oxitec’s 2nd Generation Aedes aegypti Technology in Resource-limited, Dengue-prone Urban Settings

In plain English

AI plain-English summary

Oxitec is preparing to scale up its second-generation genetically modified *Aedes aegypti* mosquito technology for use in dengue-prone cities where resources are limited. More than half the world’s population lives where *Aedes aegypti* mosquitoes are present, yet the newest, most targeted control tools remain financially and operationally out of reach for the communities that need them most. Meanwhile, the mosquito is expanding its geographical range and growing resistant to conventional insecticides. This project aims to close that gap by turning nearly a decade of research and development into a proven, affordable, and integrated solution. If successful, this work could transform how low-resource urban settings manage dengue and other mosquito-borne diseases. Instead of relying solely on insecticides that are losing effectiveness, governments and communities could deploy a simple, cost-effective biological control tool that targets only *Aedes aegypti*. The technology is designed to be accessible to a broad range of end-users, potentially shifting the burden of disease control from centralised programmes to local action.

View original technical description
Our team envisions a world in which dengue and other diseases transmitted by Aedes aegypti are ultimately eliminated. We believe the path to realizing this vision will require a large-scale democratization of a new generation of safe, effective, and targeted Aedes aegypti control technologies, ultimately allowing governments and communities alike to deploy simple, cost-effective solutions in a range of settings where it matters the most. More than half of the world’s population live in areas where the Aedes aegypti mosquito is present. For the majority, a new generation of effective, targeted and safe vector control tools are far out of reach financially and operationally, thereby limiting the potential that these novel technologies can play. At the same time, disease transmission from Aedes aegypti continues to rise as it expands both its geographical range and its level of resistance to insecticides. This critical project will help Oxitec finalize close to 10 years of investment and R&D and transform its powerful technology into a proven, affordable, scalable, accessible, and integrated solution ideal for use by a range of end-users in low-resource settings, thereby furthering enlisting a broader range of stakeholders in our collective efforts on the path to our vision.

View the original record at the funder ↗

Researchers

Grey Frandsen (EPMC Awardee)Kevin Gorman (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Development of a novel genetic population suppression system in the mosquito species Aedes aegypti
Genomes and synthetic biology for development of novel pest control technologies
13TSB_TIBio: Genomes and synthetic biology for development of novel pest control technologies
Integrating ecology and genetics for insect pest control
Demonstrating impact of mosquito-assisted larviciding (autodissemination) as a complementary malaria intervention in rural Tanzania

Original classification

Innovations Priority Project

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.